Regulated expression by PPARα and unique localization of 17β-hydroxysteroid dehydrogenase type 11 protein in mouse intestine and liver

被引:31
|
作者
Yokoi, Yasuhide [1 ]
Horiguchi, Yuka [1 ]
Araki, Makoto [1 ]
Motojima, Kiyoto [1 ]
机构
[1] Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan
关键词
hydroxysteroid dehydrogenase; immunocytochemistry; intestine; lipid droplet; proliferator-activated receptor;
D O I
10.1111/j.1742-4658.2007.06005.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
17 beta-Hydroxysteroid dehydrogenase type 11 (17 beta-HSD11) is a member of the short-chain dehydrogenase/reductase family involved in the activation and inactivation of sex steroid hormones. We recently identified 17 beta-HSD11 as a gene that is efficiently regulated by peroxisome proliferator-activated receptor-alpha PPAR alpha in the intestine and the liver [Motojima K (2004) Eur J Biochem271, 4141-4146]. In this study, we characterized 17 beta-HSD11 at the protein level to obtain information about its physiologic role in the intestine and liver. For this purpose, specific antibodies against 17 beta-HSD11 were obtained. Western blotting analysis showed that administration of a peroxisome proliferator-activated receptor-alpha agonist induced 17 beta-HSD11 protein in the jejunum but not in the colon, and to a much higher extent than in the liver of mice. A subcellular localization study using Chinese hamster ovary cells and green fluorescent protein-tagged 17 beta-HSD11 showed that it was mostly localized in the endoplasmic reticulum under normal conditions, whereas it was concentrated on lipid droplets when they were induced. A pulse-chase experiment suggested that 17 beta-HSD11 was redistributed to the lipid droplets via the endoplasmic reticulum. Immunohistochemical analysis using tissue sections showed that 17 beta-HSD11 was induced mostly in intestinal epithelia and hepatocytes, with heterogeneous localization both in the cytoplasm and in vesicular structures. A subcellular fractionation study of liver homogenates confirmed that 17 beta-HSD11 was localized mostly in the endoplasmic reticulum when mice were fed a normal diet, but was distributed in both the endoplasmic reticulum and the lipid droplets of which formation was induced by feeding a diet containing a proliferator-activated receptor-alpha agonist. Taken together, these data indicate that 17 beta-HSD11 localizes both in the endoplasmic reticulum and in lipid droplets, depending on physiologic conditions, and that lipid droplet 17 beta-HSD11 is not merely an endoplasmic reticulum contaminant or a nonphysiologically associated protein in the cultured cells, but a bona fide protein component of the membranes of both intracellular compartments.
引用
收藏
页码:4837 / 4847
页数:11
相关论文
共 11 条
  • [1] 17β-hydroxysteroid dehydrogenase type 11 is a major peroxisome proliferator-activated receptor α-regulated gene in mouse intestine
    Motojima, K
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (20): : 4141 - 4146
  • [2] 17β-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein
    Horiguchi, Yuka
    Araki, Makoto
    Motojima, Kiyoto
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 370 (02) : 235 - 238
  • [3] Identification and characterization of the ER/lipid droplet-targeting sequence in 17β-hydroxysteroid dehydrogenase type 11
    Horiguchi, Yuka
    Araki, Makoto
    Motojima, Kiyoto
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2008, 479 (02) : 121 - 130
  • [4] Promoter analyses of human and mouse 17beta-hydroxysteroid dehydrogenase type 7
    Ohnesorg, T
    Adamski, J
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 94 (1-3): : 259 - 261
  • [5] Liver X receptor α induces 17 β-hydroxysteroid dehydrogenase-13 expression through SREBP-1c
    Su, Wen
    Peng, Jun
    Li, Sha
    Dai, Yu-bing
    Wang, Chun-jiong
    Xu, Hu
    Gao, Min
    Ruan, Xiong-zhong
    Gustafsson, Jan-Ake
    Guan, You-fei
    Zhang, Xiao-yan
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2017, 312 (04): : E357 - E367
  • [6] Abnormal expression of 11β-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation
    E H Rabbitt
    J Ayuk
    K Boelaert
    M C Sheppard
    M Hewison
    P M Stewart
    N J L Gittoes
    Oncogene, 2003, 22 : 1663 - 1667
  • [7] Suppressed expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma
    Zakharov, Vladislav
    Lin, Hsueh-Kung
    Azzarello, Joseph
    McMeekin, Scott
    Moore, Kathleen N.
    Penning, Trevor M.
    Fung, Kar-Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2010, 3 (06): : 608 - 617
  • [8] Expression of 11β-hydroxysteroid Dehydrogenase Type 1 in Breast Cancer and Adjacent Non-Malignant Tissue. An Immunocytochemical Study
    Lu, Lu
    Zhao, Gang
    Luu-The, Van
    Ouellet, Johanne
    Fan, Zhinmin
    Labrie, Fernand
    Pelletier, Georges
    PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) : 627 - 632
  • [9] Differential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system
    Park, Aubrey L.
    Lin, Hsueh-Kung
    Yang, Qing
    Sing, Chor Wing
    Fan, Michael
    Mapstone, Timothy B.
    Gross, Naina L.
    Gumerlock, Mary K.
    Martin, Michael D.
    Rabb, Craig H.
    Fung, Kar-Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2010, 3 (08): : 743 - 754
  • [10] Downregulation of estrogen-metabolizing 17β-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development
    Oduwole, OO
    Isomaa, VV
    Nokelainen, PA
    Stenbäck, F
    Vihko, PT
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (01) : 1 - 6